EBM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Evidence-Based Medicine 2007;12:49; doi:10.1136/ebm.12.2.49
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peters, J. I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peters, J. I
Topic Collections
Right arrowRelated Article

Treatment

Addition of peak flow monitoring to symptom monitoring did not improve healthcare visits, quality of life, or lung function in older adults with moderate-to-severe asthma

Buist AS, Vollmer WM, Wilson SR, et al. A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma. Am J Respir Crit Care Med 2006;174:1077–87.[Abstract/Free Full Text]

Q In older adults with moderate-to-severe asthma, is symptom monitoring plus peak flow monitoring (PFM) (used as part of a comprehensive management plan) better than symptom monitoring alone for healthcare use, quality of life, and lung function?

Key Words: asthma • peak expiratory flow rate • monitoring (physiologic)

The first 150 words of the full text of this article appear below.

METHODS
Formula Design: randomised controlled trial.

Formula Allocation: {concealed}*.{dagger}

Formula Blinding: blinded (data collectors and {healthcare providers}*).{dagger}

Formula Follow up period: up to 2 years.

Formula Setting: a large managed care organisation in Oregon, USA.

Formula Patients: 296 adults 50–92 years of age (mean age 66 y, 52% women) who had physician diagnosed asthma, medication use suggestive of moderate-to-severe asthma, bronchodilator reversibility (>8% of baseline FEV1), and demonstrated ability to keep a daily symptom diary.

Formula Intervention: symptom monitoring plus PFM (n = 149) or symptom monitoring only (n = 147). All patients attended four 90 minute small group sessions that included development of personalised action plans and review of asthma diaries. Patients were instructed in the proper use of metered dose inhalers (MDIs), with individual coaching based on a skill checklist (patients had to meet >=7 of 8 skills criteria). Researchers met with patients semiannually to review techniques, daily diaries, and action plans, and . . . [Full text of this article]

Jay I Peters, MD

University of Texas Health Science Center at San Antonio, Texas, USA


Related Article

Other articles noted
Evid. Based Med. 2007 12: 63-64. (in ) [Extract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd.